Analysis of molecular heterogeneity of PRL is important in patients with hyperprolactinemia

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue

Abstract

Assessment of prolactin level in a medical laboratory is most frequently related to verifying the cause of the problems with fertility. However, hyperprolactinaemia diagnosis by laboratory test often does not reflect the clinical condition of a patient. Patients with hyperprolactinemia, but without characteristic symptoms related to this disorder, undergo further biochemical and/or image diagnosis, which could be harmful to the human organism. In some cases, pharmacological treatment and even surgical intervention are applied, although the cause of elevated prolactin levels has not been identified. Prolactin is present in blood in different forms and/or complexes. Most frequently, three basic isoforms of this hormone are distinguished: monomeric prolactin, big-prolactin, and big-big-prolactin, called a macroprolactin. The listed forms of prolactin have different biological activity, but in laboratory tests, all of them show immunoreactiveness. For that reason, prolactin is a large problem for laboratory diagnosticians and clinicians. The analysis of the presence of macroprolactin in blood samples with elevated prolactin level is not a routine matter, even though it has a key meaning in the further diagnostic process of hyperprolactinemia. A gold standard identifying all forms of prolactin is gel filtration chromatography, which gives qualitative and also quantitative results. Unfortunately, the equipment used for this method is not commonly available in medical laboratory. Results of many studies showed that the precipitation of macroprolactin with polyethylene glycol could be the screening method for evaluating the macroprolactinaemia prevalence. This procedure is simple and relatively low-cost, and though it has some analytical restrictions, its results correlate well with the results of the gel filtration chromatography. Macroprolactinaemia is present in a small percentage of the total population; however, it can occured in 53% patients with hyperprolactinaemia.

Authors and Affiliations

Izabela Kokot, Sylwia Płaczkowska, Lilla Pawlik-Sobecka

Keywords

Related Articles

The role of YKL-40 in a cancerous process

YKL-40 is a secretory protein secreted among others by tumor cells and tumor-associated macrophages. Due to the structural homology this protein was classified to chitinases family CLP (chitinase – like protein) and to 1...

Regulation of Toll-like receptors-dependent inflammatory response

Toll-like receptors (TLRs) are a pivotal part of our innate immune response. They recognize a wide variety of pathogens and instigate an immune response, thus facilitating the removal of the disease-causing agent. Due to...

Rola genów kodujących immunoglobulinopodobne receptory komórek cytotoksycznych (KIR) oraz ich ligandy w podatności i przebiegu zakażenia HIV

Komórki NK stanowią element nieswoistej odpowiedzi przeciwwirusowej, a ich aktywność jest regulowana przez sygnały wysyłane przez receptory na ich powierzchni. Należą do nich receptory immunoglobulinopodobne (KIR, killer...

Znaczenie diagnostyczne nowego markera KIM-1 w uszkodzeniach nerek

Rozwijające się lawinowo w ostatnich latach badania naukowe, wyłaniają nowe markery do oceny nieuchwytnego dotychczas okresu choroby przed ujawnieniem się jej skutków klinicznych.Dzięki badaniom eksperymentalnym przeprow...

Receptor p75NTR – rola w procesach wzrostu i śmierci komórki

Istotne dla rozwoju układu nerwowego czynniki troficzne oddziałują z komórkami za pośrednictwem receptorów o aktywności kinazy tyrozynowej (Trk) zazwyczaj przekazujących sygnał do wzrostu i przeżycia oraz z receptorem p...

Download PDF file
  • EP ID EP248753
  • DOI 10.5604/01.3001.0010.7732
  • Views 156
  • Downloads 0

How To Cite

Izabela Kokot, Sylwia Płaczkowska, Lilla Pawlik-Sobecka (2017). Analysis of molecular heterogeneity of PRL is important in patients with hyperprolactinemia. Advances in Hygiene and Experimental Medicine, 71(), 1209-1215. https://europub.co.uk/articles/-A-248753